Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 7 | 2020 | 346 | 1.270 |
Why?
|
| Continuity of Patient Care | 4 | 2017 | 168 | 0.740 |
Why?
|
| Patient Participation | 3 | 2020 | 208 | 0.700 |
Why?
|
| Primary Health Care | 4 | 2024 | 641 | 0.650 |
Why?
|
| Patient Readmission | 3 | 2015 | 416 | 0.520 |
Why?
|
| Office Visits | 2 | 2014 | 41 | 0.480 |
Why?
|
| Patient Discharge | 6 | 2017 | 477 | 0.460 |
Why?
|
| Reminder Systems | 3 | 2020 | 71 | 0.450 |
Why?
|
| Ambulatory Care | 2 | 2014 | 295 | 0.430 |
Why?
|
| Text Messaging | 3 | 2020 | 74 | 0.360 |
Why?
|
| Patient Portals | 2 | 2020 | 45 | 0.320 |
Why?
|
| Vaccination | 2 | 2020 | 333 | 0.280 |
Why?
|
| Aged | 20 | 2024 | 13221 | 0.260 |
Why?
|
| Smoking Cessation | 2 | 2022 | 532 | 0.260 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 4 | 2013 | 150 | 0.250 |
Why?
|
| Aged, 80 and over | 12 | 2022 | 5046 | 0.250 |
Why?
|
| Medication Errors | 3 | 2021 | 115 | 0.240 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2023 | 23 | 0.220 |
Why?
|
| Mobile Applications | 2 | 2024 | 124 | 0.210 |
Why?
|
| Hypertension | 2 | 2020 | 598 | 0.190 |
Why?
|
| Drug Monitoring | 3 | 2011 | 98 | 0.190 |
Why?
|
| Physician-Patient Relations | 1 | 2024 | 381 | 0.190 |
Why?
|
| Medication Systems | 1 | 2021 | 18 | 0.190 |
Why?
|
| Male | 19 | 2024 | 27286 | 0.190 |
Why?
|
| Influenza, Human | 2 | 2020 | 187 | 0.180 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 62 | 0.180 |
Why?
|
| Communication | 1 | 2024 | 531 | 0.170 |
Why?
|
| Female | 19 | 2024 | 30581 | 0.170 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 141 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 662 | 0.170 |
Why?
|
| Patient Care | 1 | 2020 | 76 | 0.170 |
Why?
|
| Pharmacists | 1 | 2021 | 123 | 0.170 |
Why?
|
| Humans | 26 | 2024 | 58880 | 0.170 |
Why?
|
| Physicians, Primary Care | 2 | 2017 | 71 | 0.170 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 325 | 0.160 |
Why?
|
| Patient Selection | 1 | 2020 | 440 | 0.150 |
Why?
|
| Motivation | 1 | 2020 | 266 | 0.150 |
Why?
|
| Influenza Vaccines | 1 | 2018 | 88 | 0.140 |
Why?
|
| Accidental Falls | 1 | 2018 | 144 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 671 | 0.140 |
Why?
|
| Massachusetts | 3 | 2021 | 2078 | 0.140 |
Why?
|
| Middle Aged | 10 | 2024 | 16134 | 0.130 |
Why?
|
| Transitional Care | 1 | 2015 | 25 | 0.130 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 234 | 0.130 |
Why?
|
| Medical Informatics | 1 | 2015 | 68 | 0.120 |
Why?
|
| Skilled Nursing Facilities | 1 | 2015 | 84 | 0.120 |
Why?
|
| Sulfonylurea Compounds | 1 | 2014 | 14 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1113 | 0.110 |
Why?
|
| Meaningful Use | 1 | 2013 | 8 | 0.110 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2013 | 56 | 0.110 |
Why?
|
| Health Records, Personal | 1 | 2013 | 26 | 0.110 |
Why?
|
| Metformin | 1 | 2014 | 67 | 0.110 |
Why?
|
| Diabetes Complications | 1 | 2013 | 102 | 0.100 |
Why?
|
| Ambulatory Care Information Systems | 1 | 2012 | 8 | 0.100 |
Why?
|
| Comorbidity | 3 | 2023 | 1084 | 0.100 |
Why?
|
| Ambulatory Care Facilities | 2 | 2010 | 101 | 0.100 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 209 | 0.100 |
Why?
|
| Weight Loss | 1 | 2013 | 259 | 0.090 |
Why?
|
| Pharmaceutical Preparations | 2 | 2010 | 121 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 328 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 158 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 244 | 0.080 |
Why?
|
| Safety Management | 1 | 2010 | 142 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 2316 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2014 | 5922 | 0.080 |
Why?
|
| Telemedicine | 1 | 2013 | 327 | 0.080 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 2 | 2004 | 51 | 0.070 |
Why?
|
| Hospitalization | 3 | 2021 | 1272 | 0.070 |
Why?
|
| Adult | 5 | 2024 | 15609 | 0.070 |
Why?
|
| Antihypertensive Agents | 2 | 2020 | 172 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2024 | 249 | 0.060 |
Why?
|
| Incidence | 3 | 2014 | 1226 | 0.060 |
Why?
|
| Time Factors | 3 | 2017 | 3544 | 0.060 |
Why?
|
| Group Practice | 1 | 2003 | 12 | 0.050 |
Why?
|
| Drug Therapy | 1 | 2003 | 61 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1441 | 0.050 |
Why?
|
| Prostate-Specific Antigen | 1 | 2022 | 65 | 0.050 |
Why?
|
| Technology | 1 | 2022 | 48 | 0.050 |
Why?
|
| Carbon Monoxide | 1 | 2022 | 59 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2020 | 1047 | 0.050 |
Why?
|
| New England | 3 | 2010 | 267 | 0.050 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2020 | 4 | 0.050 |
Why?
|
| Renin-Angiotensin System | 1 | 2020 | 22 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2023 | 467 | 0.050 |
Why?
|
| Eligibility Determination | 1 | 2020 | 34 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 134 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 115 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2015 | 910 | 0.040 |
Why?
|
| Mammography | 1 | 2022 | 270 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2018 | 1893 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 260 | 0.040 |
Why?
|
| Reward | 1 | 2020 | 80 | 0.040 |
Why?
|
| Goals | 1 | 2020 | 89 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 4279 | 0.040 |
Why?
|
| Focus Groups | 1 | 2020 | 290 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2014 | 432 | 0.040 |
Why?
|
| Adolescent | 2 | 2020 | 5871 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 263 | 0.040 |
Why?
|
| Motivational Interviewing | 1 | 2018 | 41 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 419 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 603 | 0.040 |
Why?
|
| Telephone | 1 | 2018 | 121 | 0.040 |
Why?
|
| Mass Screening | 1 | 2022 | 637 | 0.040 |
Why?
|
| Research Design | 1 | 2020 | 561 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2020 | 840 | 0.030 |
Why?
|
| Age Factors | 2 | 2014 | 1517 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 4975 | 0.030 |
Why?
|
| Propensity Score | 1 | 2014 | 130 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2014 | 256 | 0.030 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2014 | 10 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2014 | 161 | 0.030 |
Why?
|
| Insurance Claim Review | 1 | 2014 | 80 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 105 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2013 | 23 | 0.030 |
Why?
|
| United States | 3 | 2014 | 7441 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2013 | 42 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2013 | 2429 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 674 | 0.030 |
Why?
|
| Inappropriate Prescribing | 1 | 2013 | 67 | 0.030 |
Why?
|
| Health Expenditures | 1 | 2014 | 115 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 925 | 0.030 |
Why?
|
| Patient Safety | 1 | 2014 | 235 | 0.020 |
Why?
|
| Data Collection | 1 | 2013 | 382 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 780 | 0.020 |
Why?
|
| Prescription Drugs | 1 | 2011 | 50 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 518 | 0.020 |
Why?
|
| Length of Stay | 1 | 2014 | 760 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2012 | 113 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 402 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 890 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 820 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 2444 | 0.010 |
Why?
|
| Diuretics | 1 | 2004 | 58 | 0.010 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2004 | 35 | 0.010 |
Why?
|
| Medical Records | 1 | 2004 | 137 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2004 | 92 | 0.010 |
Why?
|
| Medicare Part B | 1 | 2003 | 10 | 0.010 |
Why?
|
| Medicare Part C | 1 | 2003 | 15 | 0.010 |
Why?
|
| Sex Factors | 1 | 2004 | 957 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2004 | 485 | 0.010 |
Why?
|
| Medicare | 1 | 2004 | 601 | 0.010 |
Why?
|